Pharmaceutical Supply,
Explained Clearly.

How the 2026 NUPCO localisation framework reshapes Saudi pharmaceutical procurement, and the three exempt segments where UK MHRA exporters still play: named patient, shortage, and specialty supply.

UAE pharmaceutical import permit process across MOHAP, DHA and DOH. Free zone vs mainland, named patient pathways, hospital procurement and 2026 e-system updates.

Step-by-step SFDA process for UK pharmaceutical exporters. CPP documentation, batch release, named patient route, NUPCO supply pathways and 2026 localisation rules.

Qatar Ministry of Public Health pharmaceutical import for UK exporters. HMC procurement, Sidra Medicine, named patient pathways, FIFA World Cup 2022 logistics legacy.

Egyptian Drug Authority pharmaceutical import for UK exporters. Cairo customs, hospital procurement networks, named patient access, pricing controls and Universal Health Insurance rollout.

How Levant and Iraqi hospitals source UK-licensed medicines. Covers Lebanon MoPH, Jordan JFDA, Iraq Kimadia regulatory frameworks, named patient pathways and documentation standards.

How Francophone African hospitals source UK-licensed medicines. Covers Algeria LNCPP, Cote d'Ivoire DPML, DRC ACOREP, Senegal DPM and Morocco DMP regulatory pathways.

WDA(H) vs WDA(IMP), MHRA application process, GDP requirements, site inspections, Responsible Person duties, common deficiencies and how to verify a licensed UK supplier.

Temperature categories, GDP requirements, validated packaging systems, monitoring technology and common failure points. A practical guide for anyone importing temperature-sensitive medicines.

Covers SFDA, MOHAP, EDE registration, special access pathways, GCC centralised drug registration, cold chain logistics and full documentation requirements for Gulf pharmaceutical imports.

Practical guide for hospitals, health ministries and NGOs. Covers NAFDAC, PPB, FDA Ghana, SAHPRA and EFDA import requirements, documentation and logistics from Heathrow.

Supplier qualification, export documentation, the step-by-step sourcing process, and how to access unlicensed medicines, a practical guide for GCC and Africa buyers.

MHRA recall alert for specific batches of rabies immunoglobulin. What hospital pharmacy and procurement teams in the UK and export markets need to know about stock management and alternative sourcing.

Why UK medicine shortages are at a record high, the structural causes behind them, and what procurement options hospitals have when licensed supply fails.

What Good Distribution Practice means for international procurement, the nine chapters of GDP, MHRA enforcement, documentation standards, and how to verify a UK supplier's compliance.

London-based distributor brings licensed UK-sourced medicines to healthcare systems across 40+ countries, backed by full MHRA WDA and GDP compliance.

What named patient supply actually means, when it applies, how the UK legal framework works, and how to source unlicensed medicines compliantly.

Regent Medical Limited, acting for Molnlycke Health Care, has recalled specific batches of Hibiwash 500ml due to microbial contamination identified at the manufacturing facility.

Bayer has recalled various products under EL(26)A/12 due to an impurity concern. What hospital and community pharmacy teams need to know about affected batches and sourcing alternatives.

Crescent Pharma has recalled specific batches of Ramipril 5mg Capsules due to a manufacturing error. What hospital pharmacy and dispensing teams need to know about this Class 2 recall.

A Class 4 Drug Alert has been issued for Dropodex Eye Drops due to missing phosphate information in the product information. Action required for ophthalmology pharmacy teams.

All batches of KidNaps Melatonin have been recalled following stability testing failure. Class 2 recall affecting paediatric sleep disorder prescribers and pharmacy teams holding any stock.

Norgine has recalled MOVICOL Ease Citrus under EL(26)A/08 due to low active ingredient content. What hospital and community pharmacy teams need to know about affected batches and continuing laxative supply.

Aspar Pharmaceuticals has recalled Ibuprofen 200mg Tablets under EL(26)A/07 due to a foil perforation issue affecting packaging integrity. What pharmacy and procurement teams need to know.

A Class 2 recall has been issued for Baclofen Oral Solution due to a risk of crystallisation that could affect dose accuracy. What neurology and spasticity pharmacy teams need to know.

Accord Healthcare has recalled a single batch of Carmustine 100mg due to an out-of-specification test result. What oncology pharmacy teams holding affected stock need to know and how to source alternatives.

A Class 1 medicines recall has been issued for Quetiapine Oral Suspension due to a risk of overdose from concentration or labelling errors. Urgent action required for all pharmacy teams holding affected stock.